you can’t work it out from Abbvie financials because they group it in with aesthetics, but the report BOT made from interviewing dermatologists listed prescribing Botox for 5% of first line, 24% of second line patients. The introduction of SB didn’t really change the Botox patients, mainly topical, Qbrexza and orals.
you can’t work it out from Abbvie financials because they group...
-
- There are more pages in this discussion • 2,663 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.5¢ | 37.5¢ | $1.701M | 4.493M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 523247 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 146093 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |